Table 2.
Sociodemographic and clinical characteristics of patients.
| Variables | No. (%) |
|---|---|
| Gender | |
| Male | 276(61.3) |
| Female | 174 (38.7) |
| Age (years) | |
| 25–30 | 129 (28.7) |
| 41–55 | 168 (37.3) |
| >55 | 123 (34.0) |
| Body mass index (kg/m2) | |
| Underweight (< 18.5) | 8 (1.8) |
| Normal (18.5–24.9) | 69 (15.3) |
| Overweight (25.0–29.9) | 211 (46.9) |
| Obese (>30.0) | 162 (36.0) |
| Duration of diabetes mellitus | |
| <1 year | 11 (2.4) |
| 1–5 year | 108 (24.0) |
| >5 year | 331 (73.6) |
| Family history of cardiovascular diseases | 295 (65.6) |
| Comorbidities | |
| No | 180 (40.0) |
| 1–2 | 76 (16.9) |
| >2 | 194 (43.1) |
| Type of comorbidity | |
| Stroke | 49 (10.1) |
| Hypertension | 355 (78.9) |
| Dyslipidemia | 245 (54.4) |
| Cardiovascular disease | 114 (25.3) |
| Heart failure | 20 (4.4) |
| Coronary heart disease | 97 (21.6) |
| Chronic kidney disease Stage-III a (eGFR = 45–59 ml/min/1.73 m2) Stage-III a (eGFR = 45–59 ml/min/1.73 m2) Stage-4 (eGFR = 15–29 ml/min/1.73 m2) Stage-5 (eGFR < 15 ml/min/1.73m2) Stage unknown |
86 (19.1) 33 17 11 4 21 |
| Others | 110 (24.4) |
eGFR, estimated glomerular filtration rate; min, minute; ml, milliliter; m, meter.